Kriangkrai Tawinprai

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Venues

Human vaccines & immunotherapeutics

JCO global oncology

Vaccines

Diabetology international

This page only lists publications with an associated author ORCID identifier.

Publications

Chayanee Samdaengpan, Prakongboon Sungkasubun, Worawit Chaiwiriyawong, Archara Supavavej, Jomtana Siripaibun, Chumut Phanthunane, Walaipan Tantiyavarong, Wisut Lamlertthon, Teerapat Ungtrakul, Kriangkrai Tawinprai, Kamonwan Soonklang, Thitapha Thongchai, Piyarat Limpawittayakul
Effect of Corticosteroid on Immunogenicity of SARS-CoV-2 Vaccines in Patients With Solid Cancer. JCO global oncology 10 (2024)
Chayanee Samdaengpan, Prakongboon Sungkasubun, Worawit Chaiwiriyawong, Archara Supavavej, Jomtana Siripaibun, Chumut Phanthunane, Walaipan Tantiyavarong, Wisut Lamlertthon, Teerapat Ungtrakul, Kriangkrai Tawinprai, Kamonwan Soonklang, Thitapha Thongchai, Piyarat Limpawittayakul
Effect of Corticosteroid on Immunogenicity of SARS-CoV-2 Vaccines in Patients With Solid Cancer. JCO global oncology 10 (2024)
Thachanun Porntharukchareon, Wipada Chartisathian, Manassamon Navinpipat, Chayanee Samdaengpan, Kunsuda Cheirsilpa, Aimwipa Lueprasitsakul, Supanat Worawichawong, Viroj Muangsillapasart, Pratya Pumuthaivirat, Bothamai Dechates, Supamas Sirisreetreerux, Taweegrit Siripongboonsitti, Vimonsri Rangsrisaeneepitak, Kerati Jirawattanapalin, Kriangkrai Tawinprai
The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study. Human vaccines & immunotherapeutics 19 (2) (2023)
Walaipan Tantiyavarong, Prakongboon Sungkasubun, Worawit Chaiwiriyawong, Archara Supavavej, Piyarat Limpawittayakul, Bowon Weerasubpong, Jomtana Siripaibun, Chumut Phanthunane, Wisut Lamlertthon, Teerapat Ungtrakul, Kriangkrai Tawinprai, Pichaya Tantiyavarong, Chayanee Samdaengpan
Difference in Immunogenic Responses to COVID-19 Vaccines in Patients With Cancer Receiving Chemotherapy Versus Nonchemotherapy Treatment. JCO global oncology 9 (2023)
Kriangkrai Tawinprai, Pawornrath Jungsomsri, Onnicha Pinijnai, Fahsiri Tavonvunchai, Anchisa Lievjaroen, Paphada Suwannaroj, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Gaidganok Sornsamdang, Teerapat Ungtrakul
Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study. Human vaccines & immunotherapeutics (2023)
Chayapa Thookhamme, Manassamon Navinpipat, Aimwipa Sasakul, Pakthipa Pattarakosol, Kamoltip Lertchaisataporn, Kriangkrai Tawinprai, Pannee Praditsuktavorn
Immunogenicity of the ChAdOx1 nCoV-19 vaccine in patients with hematologic malignancies. Clinical and experimental vaccine research 12 (2) (2023)
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda
Reactogenicity, immunogenicity, and humoral immune response dynamics after the third dose of heterologous COVID-19 vaccines in participants fully vaccinated with inactivated vaccine. Expert review of vaccines 21 (12) (2022)
Vimonsri Rangsrisaeneepitak, Thachanun Porntharukchareon, Bothamai Dechates, Supamas Sirisreetreerux, Kriangkrai Tawinprai
Antibody levels in people with diabetes after one dose of the ChAdOx1 nCoV-19 (AZD1222) vaccine. Diabetology international 13 (4) (2022)
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Preeda Vanichsetakul, Saraiorn Thonginnetra, Krongkwan Niemsorn, Pathariya Promsena, Manunya Tandhansakul, Naruporn Kasemlawan, Natthanan Ruangkijpaisal, Narin Banomyong, Nanthida Phattraprayoon, Teerapat Ungtrakul, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Nithi Mahanonda
Safety and Immunogenicity of the BBIBP-CorV Vaccine in Adolescents Aged 12 to 17 Years in the Thai Population: An Immunobridging Study. Vaccines 10 (5) (2022)
Saraiorn Thonginnetra, Kriangkrai Tawinprai, Krongkwan Niemsorn, Pathariya Promsena, Manunya Tandhansakul, Naruporn Kasemlawan, Natthanan Ruangkijpaisal, Narin Banomyong, Nanthida Phattraprayoon, Pisuttikan Rangkakulnuwat, Preeda Vanichsetakul, Teerapat Ungtrakul, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Nithi Mahanonda
Safety after BBIBP-CorV (Sinopharm) COVID-19 Vaccine in Adolescents Aged 10-17 Years in Thailand. Vaccines 10 (10) (2022)
Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Bothamai Dechates, Harnphadungkit Monprach, Gaidganok Sornsamdang, Kasiruck Wittayasak, Kamonwan Soonklang, Nithi Mahanonda
Persistence of immunogenicity, contributing factors of an immune response, and reactogenicities after a single dose of the ChAdOx1 (AZD1222) COVID-19 vaccine in the Thai population. Human vaccines & immunotherapeutics 18 (1) (2022)
Guy Cohen, Pawornrath Jungsomsri, Jirath Sangwongwanich, Kriangkrai Tawinprai, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Kasiruck Wittayasak, Nawarat Thonwirak, Kamonwan Soonklang, Gaidganok Sornsamdang, Chirayu Auewarakul, Nithi Mahanonda
Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines. Human vaccines & immunotherapeutics 18 (5) (2022)

Kriangkrai Tawinprai.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kriangkrai Tawinprai